COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1294: Articles 12931-12940  | Next

COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women: a population study
Serra, F. E., Francisco, R. P. V., de Rossi, P., Brizot, M. d. L., Rodrigues, A. S.
10.1101/2021.07.27.21261163 — Posted: 2021-07-31
Predictors of COVID-19 vaccination uptake and reasons for decline of vaccination: a systematic review
Galanis, P. A., Vraka, I., Siskou, O., Konstantakopoulou, O., Katsiroumpa, A., Kaitelidou, D.
10.1101/2021.07.28.21261261 — Posted: 2021-07-31
Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals. A systematic review
Jefferson, T., Spencer, E. A., Brassey, J., Onakpoya, I., Rosca, E., Pluddeman, A., Evans, D., Conly, J., Heneghan, C.
10.1101/2021.07.28.21261254 — Posted: 2021-07-31
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of SARS-CoV-2 infectivity
Diomede, L., Baroni, S., De Luigi, A., Piotti, A., Lucchetti, J., Fracasso, C., Russo, L., Bonaldo, V., Panini, N., Filippini, F., Fiordaliso, F., Corbelli, A., Beeg, M., Pizzato, M., Caccuri, F., Gobbi, M., Biasini, E., Caruso, A., Salmona, M.
10.1101/2021.07.30.454436 — Posted: 2021-07-30
Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition
Navaratnarajah, C. K., Pease, D. R., Halfmann, P., Taye, B., Barkhymer, A., Howell, K. G., Charlesworth, J. E., Christensen, T. A., Kawaoka, Y., Cattaneo, R., Schneider, J. W., Timothy J. Nelson (Director), Boyd Rasmussen and Frank J. Secreto
10.1101/2021.07.30.454437 — Posted: 2021-07-30
Influence of social determinants of health and county vaccination rates on machine learning models to predict COVID-19 case growth in Tennessee
Wylezinski, L. S., Harris, C. R., Heiser, C. N., Gray, J. D., Spurlock, C. F.
10.1101/2021.07.28.21260814 — Posted: 2021-07-30 Discussion: Offsite
COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters
Xu, Z., Li, Y., Lei, Q., Huang, L., Lai, D.-y., Guo, S.-j., Jiang, H.-w., Hou, H., Zheng, Y.-x., Wang, X.-n., Wu, J., Ma, M.-l., Zhang, B., Chen, H., Yu, C., Xue, J.-b., Zhang, H.-n., Qi, H., Yu, S., Lin, M., Zhang, Y., Lin, X., Yao, Z., Sheng, H., Sun, Z., Wang, F., Fan, X., Tao, S.-c.
10.1101/2021.07.29.454261 — Posted: 2021-07-30
SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1
Varela, A. P. M., Prichula, J., Meyer, F. Q., Salvato, R., Sant'Anna, F. H., Gregianini, T. S., Martins, L. G., Seixas, A., Veiga, A. B. G. d.
10.1101/2021.07.29.454323 — Posted: 2021-07-30
Identification and Characterization of novel mutants of Nsp13 Protein among Indian SARS-CoV-2 isolates.
Kumari, D., Kumari, N., Kumar, S., Sinha, P. K., Shahi, S. K., Biswas, N. R., Kumar, A.
10.1101/2021.07.30.454406 — Posted: 2021-07-30
3D printed cobalt-chromium-molybdenum porous superalloy with superior antiviral activity
Arjunan, A., Robinson, J., Baroutaji, A., Marti, M., Tunon-Molina, A., Serrano-Aroca, A.
10.1101/2021.07.29.454385 — Posted: 2021-07-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).